{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-005349","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2026-08-07T14:30:21+00:00","discovered_at":"2026-08-07T14:31:01.432770+00:00","generated_at":"2026-08-07T14:31:07.227657+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"United-Guardian Q2 net income up 16% to $728,579; sales up 10% to $3.1M","bullets":["Q2 net sales $3,108,267, up 10% from $2,838,225; net income $728,579 ($0.16/diluted), up 16% from $626,826 ($0.14).","Six-month net sales $5,980,489, up 12% from $5,319,352; net income $1,547,481 ($0.34), up 30% from $1,187,721 ($0.26).","Cosmetic ingredient sales up 44% in Q2 and 34% in H1, driven by resumed purchasing from largest distributor Ashland Specialty Ingredients (ASI).","Pharmaceutical sales up 1% in Q2 and 11% in H1, led by Renacidin; company focused on growth plan for rest of 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-005349","json":"https://secwatch.observer/filing/0001171843-26-005349.json","markdown":"https://secwatch.observer/filing/0001171843-26-005349.md","text":"https://secwatch.observer/filing/0001171843-26-005349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/0001171843-26-005349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/f8k_080726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T14:31:07.227657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}